Glassman Wealth Services Bridge Bio Pharma, Inc. Transaction History

Glassman Wealth Services

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$16.89 - $35.01 $202 - $420	-12 Reduced 44.44%	15 $0
Q1 2023 May 04, 2023	BUY	$7.17 - $18.55 $193 - $500	27 New	27 $0
Q2 2022 Aug 04, 2022	SELL	$5.21 - $12.14 $521 - $1,214	-100 Closed	0 $0
Q1 2022 Apr 14, 2022	BUY	$7.34 - $17.16 $734 - $1,716	100 New	100 $1,000
Q1 2020 May 12, 2020	SELL	$16.11 - $36.23 $128 - $289	-8 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$17.96 - $46.63 $143 - $373	8 New	8 $0

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.47B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.